Skip to main navigation Skip to search Skip to main content

Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo

  • Rohan Narayan
  • , Mansi Sharma
  • , Rajesh Yadav
  • , Abhijith Biji
  • , Oyahida Khatun
  • , Sumandeep Kaur
  • , Aditi Kanojia
  • , Christy Margrat Joy
  • , Raju Rajmani
  • , Pallavi Raj Sharma
  • , Sharumathi Jeyasankar
  • , Priya Rani
  • , Radha Krishan Shandil
  • , Shridhar Narayanan
  • , Durga Chilakalapudi Rao
  • , Vijaya Satchidanandam
  • , Saumitra Das
  • , Rachit Agarwal
  • , Shashank Tripathi

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Abstract

The COVID-19 pandemic highlights an urgent need for effective antivirals. Targeting host processes co-opted by viruses is an attractive antiviral strategy with a high resistance barrier. Picolinic acid (PA) is a tryptophan metabolite endogenously produced in mammals. Here, we report the broad-spectrum antiviral activity of PA against enveloped viruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A virus (IAV), flaviviruses, herpes simplex virus, and parainfluenza virus. Mechanistic studies reveal that PA inhibits enveloped virus entry by compromising viral membrane integrity, inhibiting virus-cellular membrane fusion, and interfering with cellular endocytosis. More importantly, in pre-clinical animal models, PA exhibits promising antiviral efficacy against SARS-CoV-2 and IAV. Overall, our data establish PA as a broad-spectrum antiviral with promising pre-clinical efficacy against pandemic viruses SARS-CoV-2 and IAV.

Original languageEnglish
Article number101127
JournalCell Reports Medicine
Volume4
Issue number8
DOIs
StatePublished - 15 Aug 2023
Externally publishedYes

Keywords

  • SARS-CoV-2
  • antiviral
  • influenza
  • membrane fusion
  • picolinic acid
  • pre-clinical animal models
  • viral entry

Fingerprint

Dive into the research topics of 'Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo'. Together they form a unique fingerprint.

Cite this